Cabozantinib approved for advanced medullary thyroid cancer

被引：21
|
作者：
Traynor, Kate
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2013年 / 70卷 / 02期
关键词：
D O I：
10.2146/news130005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [1] Cabozantinib for the Treatment of Advanced Medullary Thyroid Cancer
    Nagilla, Madhavi
    Brown, Rebecca L.
    Cohen, Ezra E. W.
    ADVANCES IN THERAPY, 2012, 29 (11) : 925 - 934
  • [2] Cabozantinib for the Treatment of Advanced Medullary Thyroid Cancer
    Madhavi Nagilla
    Rebecca L. Brown
    Ezra E. W. Cohen
    Advances in Therapy, 2012, 29 : 925 - 934
  • [3] Cabozantinib for patients with medullary thyroid cancer
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (11): : E444 - E444
  • [4] Cabozantinib in Progressive Medullary Thyroid Cancer
    Elisei, Rossella
    Schlumberger, Martin J.
    Mueller, Stefan P.
    Schoffski, Patrick
    Brose, Marcia S.
    Shah, Manisha H.
    Licitra, Lisa
    Jarzab, Barbara
    Medvedev, Viktor
    Kreissl, Michael C.
    Niederle, Bruno
    Cohen, Ezra E. W.
    Wirth, Lori J.
    Ali, Haythem
    Hessel, Colin
    Yaron, Yifah
    Ball, Douglas
    Nelkin, Barry
    Sherman, Steven I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3639 - +
  • [5] Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer
    Hart, Christopher D.
    De Boer, Richard H.
    ONCOTARGETS AND THERAPY, 2013, 6 : 1 - 7
  • [6] Cabozantinib Approved for Previously Treated Differentiated Thyroid Cancer
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (10) : 649 - 649
  • [7] Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer
    Koehler, Viktoria F.
    Adam, Pia
    Frank-Raue, Karin
    Raue, Friedhelm
    Berg, Elke
    Hoster, Eva
    Allelein, Stephanie
    Schott, Matthias
    Kroiss, Matthias
    Spitzweg, Christine
    THYROID, 2021, 31 (03) : 459 - 469
  • [8] Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer
    Krajewska, Jolanta
    Olczyk, Tomasz
    Jarzab, Barbara
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (01) : 69 - 79
  • [9] Cabozantinib for progressive metastatic medullary thyroid cancer: a review
    Colombo, Joshua R.
    Wein, Richard O.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 395 - 404
  • [10] Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer
    Viola, David
    Cappagli, Virginia
    Elisei, Rossella
    FUTURE ONCOLOGY, 2013, 9 (08) : 1083 - 1092
12345